About Baxter BioScience
Baxter Healthcare Corporation provides critical therapies for people with life-threatening conditions. Baxter is a leading manufacturer of plasma-based and recombinant proteins used to treat hemophilia. Other biopharmaceutical products include plasma-based therapies to manage immune disorders, alpha-1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter also is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.
Some of the therapies offered by Baxter BioScience are GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% for Primary Immune Deficiencies, WinRho® SDF [Rho(D) Immune Globulin Intravenous (Human)] for Immune Thrombocytopenic Purpura, ARALAST NP [Alpha1-Proteinase Inhibitor (Human)] for Alpha-1 Antitrypsin Deficiency, CEPROTIN [Protein C Concentrate (Human)] for Protein C Deficiency, and ADVATE [Antihemophilic Factor (Recombinant)] and FEIBA VH [Anti-inhibitor Coagulant Complex] for Hemophilia treatment. Baxter also offers albumin therapy fluid volume replacement products such as FLEXBUMIN 25% [Albumin (Human)].
Today, Baxter continues to develop innovative treatments and therapies that address unmet medical needs and improve the lives of people worldwide with chronic and acute conditions. For a more in-depth look at Baxter's history of healthcare innovation, and to read about our involvement within different patient communities, please visit Baxter.com.
Please see the Important Risk Information for ADVATE [Antihemophilic Factor (Recombinant)].
Please see the Full Prescribing Information for ADVATE supplied with BAXJECT II.
Please see the Full Prescribing Information for ADVATE supplied with Double Ended Needles.
Please see the Important Risk Information for ARALAST NP [Alpha1-Proteinase Inhibitor (Human)] and Full Prescribing Information.
Please see the Important Risk Information for CEPROTIN [Protein C Concentrate (Human)] and Full Prescribing Information.
Please see the Important Risk Information for FEIBA VH [Anti-Inhibitor Coagulant Complex] and Full Prescribing Information.
Please see the Important Risk Information for FLEXBUMIN 25% [Albumin (Human)] and Full Prescribing Information.
Please see the Important Risk Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% and Full Prescribing Information.
Please see the Important Risk Information for WinRho® SDF [Rho(D) Immune Globulin Intravenous (Human)] and Full Prescribing Information.
